All Stories

  1. Histopathological and Clinical-Genetic Analysis of Corneal Specimens in Maroteaux–Lamy Syndrome
  2. Expert consensus and current landscape of NUT carcinoma: A comprehensive strategy from diagnosis to treatment
  3. Biomarker Profiling of Upper Tract Urothelial Carcinoma Only and with Synchronous or Metachronous Bladder Cancer
  4. Recapitulation of clinical features in a patient-derived xenograft mouse model of VEXAS Syndrome
  5. Cellular iron governs the host response to malaria
  6. Author Reply to Peer Reviews of Cellular iron governs the host response to malaria
  7. Generation of an Obese Diabetic Mouse Model upon Conditional Atrx Disruption
  8. Renovascular Hypertension: Unraveling a Case of Mixed Histiocytosis
  9. Cellular iron governs the host response to malaria
  10. Prognostic Value of Bladder Involvement in the Outcome of Upper Tract Urothelial Carcinoma
  11. An update on genetically engineered mouse models of pancreatic neuroendocrine neoplasms
  12. Clinicopathological features of head and neck cutaneous basal cell carcinoma observed at the Centro Hospitalar de Trás-os-Montes e Alto Douro ENT Department
  13. Characterisation of an Atrx Conditional Knockout Mouse Model: Atrx Loss Causes Endocrine Dysfunction Rather Than Pancreatic Neuroendocrine Tumour
  14. Primary adrenal angiosarcoma within a hematoma
  15. Connexin Expression in Pituitary Adenomas and the Effects of Overexpression of Connexin 43 in Pituitary Tumor Cell Lines
  16. Colonic Pseudolipomatosis: A Rare and Challenging Condition
  17. Predictive Biomarkers in Melanoma: Detection of BRAF Mutation Using Dermoscopy
  18. <b><i>TERT</i></b> Promoter Mutational Status in the Management of Cutaneous Melanoma: Comparison with Sentinel Lymph Node Biopsy
  19. TERTp mutations and p53 expression in head and neck cutaneous basal cell carcinomas with different aggressive features
  20. Combinatorial Therapies to Overcome BRAF/MEK Inhibitors Resistance in Melanoma Cells: An in vitro Study
  21. The role of c-Met and VEGFR2 in glioblastoma resistance to bevacizumab
  22. LRP1B Expression as a Putative Predictor of Response to Pegylated Liposomal Doxorubicin Treatment in Ovarian Cancer
  23. Mohs Micrographic Surgery for Head and Neck Nonmelanoma Skin Cancer: An Approach for Ent Surgeons
  24. Hepcidin-Mediated Hypoferremia Disrupts Immune Responses to Vaccination and Infection
  25. Clinical characteristics and incidence of glucose metabolism disorders during the follow-up of surgically treated insulinomas
  26. Metabolic modulation combined with mTOR pathway inhibition may overcame cutaneous melanoma resistance to MAPK inhibitors treatment
  27. Cutaneous Angiosarcoma in an Unusual Location and Without Predisposing Factors
  28. Embryonal Tumors of the Central Nervous System
  29. Predictive Biomarkers and Patient Outcome in Platinum-Resistant (PLD-Treated) Ovarian Cancer
  30. Prognostic Significance of RAS Mutations and P53 Expression in Cutaneous Squamous Cell Carcinomas
  31. Erratum to “Gastroenteropancreatic Neuroendocrine Neoplasia Characterization in Portugal: Results from the NETs Study Group of the Portuguese Society of Endocrinology, Diabetes and Metabolism”
  32. Molecular Genetic Features of Primary Nonurachal Enteric-type Adenocarcinoma, Urachal Adenocarcinoma, Mucinous Adenocarcinoma, and Intestinal Metaplasia/Adenoma: Review of the Literature and Next-generation Sequencing Study
  33. Regulation of invasion and peritoneal dissemination of ovarian cancer by mesothelin manipulation
  34. A 30-Year Long-Term Experience in Appendix Neuroendocrine Neoplasms—Granting a Positive Outcome
  35. Head and neck cutaneous basal cell carcinoma: what should the otorhinolaryngology head and neck surgeon care about?
  36. A leg ulcer with hard, yellow projections
  37. Juvenile gangrenous vasculitis of the scrotum – a diagnosis not to forget
  38. Loss of SPINT2 expression frequently occurs in glioma, leading to increased growth and invasion via MMP2
  39. Gastroenteropancreatic Neuroendocrine Neoplasia Characterization in Portugal: Results from the NETs Study Group of the Portuguese Society of Endocrinology, Diabetes and Metabolism
  40. Genetic variants identified by target next-generation sequencing in heart transplant patients with dilated cardiomyopathy
  41. Genetic variants identified by target next-generation sequencing in heart transplant patients with dilated cardiomyopathy
  42. TERT promoter mutations are associated with poor prognosis in cutaneous squamous cell carcinoma
  43. Perianal purpuric plaques revealing an amyloid light-chain amyloidosis: case report and review of the literature
  44. Periocular Sebaceous Carcinoma With Apocrine Differentiation: A Case Report and Review of the Literature
  45. Les mutations du promoteur de la télomérase sont un biomarqueur pronostique dans le carcinome épidermoïde cutané
  46. Histological Subtypes and Clinical Behavior Evaluation of Salivary Gland Tumors
  47. The genetics of cutaneous squamous cell carcinogenesis
  48. An unusual case of epistaxis due to angiofibroma of the nasal cavity
  49. Cutaneous amyloidosis as major manifestation of systemic AL-amyloidosis
  50. Melanoma treatment in review
  51. Telomere Maintenance Mechanisms in Cancer
  52. Phenotypic Intratumoral Heterogeneity of Endometrial Carcinomas
  53. Peritoneal dissemination of ovarian cancer: role of MUC16-mesothelin interaction and implications for treatment
  54. Malignant Solitary Fibrous Tumor of the Liver:AIRP Best Cases in Radiologic-Pathologic Correlation
  55. Liver transplant recipients have a higher prevalence of anal squamous intraepithelial lesions
  56. Primary intimal sarcoma of the left atrium presenting with constitutional symptoms
  57. SDHD promoter mutations are rare events in cutaneous melanomas but SDHD protein expression is downregulated in advanced cutaneous melanoma
  58. Epigenetics in endometrial carcinogenesis – part 2: histone modifications, chromatin remodeling and noncoding RNAs
  59. Jejunum/ ileum Neuroendocrine Tumours: results of a multicentric retrospective study
  60. Epigenetics in endometrial carcinogenesis – part 1: DNA methylation
  61. The role of pathology in the management of patients with endometrial carcinoma
  62. Genetic disruption of NRF2 promotes the development of necroinflammation and liver fibrosis in a mouse model of HFE-hereditary hemochromatosis
  63. Genetic polymorphisms in key hypoxia-regulated downstream molecules and phenotypic correlation in prostate cancer
  64. Adipose Tissue Tumors, Stomach
  65. C-Kit (CD117), Gastrointestinal Stromal Tumors (GISTs)
  66. Distant Metastases in Uterine Leiomyosarcomas
  67. Gastrointestinal Autonomic Nerve Tumor
  68. Gastrointestinal Stromal Tumor
  69. Glomus Tumor, Gastrointestinal
  70. Granular Cell Tumor, Gastrointestinal
  71. Inflammatory Fibroid Polyp, Upper Gastrointestinal Tract
  72. Inflammatory Myofibroblastic Tumor, Upper Gastrointestinal Tract
  73. Neuroendocrine Tumor, Esophagus
  74. Neuroendocrine Tumor, Gastric
  75. Neuroendocrine neoplasms: a brief overview emphasizing gastroenteropancreatic tumors
  76. Neurocristic hamartoma of the scalp
  77. Solitary squamoid cyst of the liver
  78. Pathologic Findings in Prophylactic and Nonprophylactic Hysterectomy Specimens of Patients With Lynch Syndrome
  79. TERT promoter mutations in pancreatic endocrine tumours are rare and mainly found in tumours from patients with hereditary syndromes
  80. Spitz/Reed nevi: a review of clinical-dermatoscopic and histological correlation
  81. The prognostic impact of TERT promoter mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism
  82. TERT promoter mutations in pancreatic endocrine tumours are frequent in tumours from patients with hereditary syndromes
  83. Metanephric adenoma: Cytological, histological, and molecular diagnosis of a case
  84. Mixed Adenoneuroendocrine Carcinoma Causing Colonic Intussusception
  85. Assessing sirtuin expression in endometrial carcinoma and non-neoplastic endometrium
  86. Basal cell carcinoma of the skin (part 1): epidemiology, pathology and genetic syndromes
  87. Basal cell carcinoma of the skin (part 2): diagnosis, prognosis and management
  88. “A book should not be judged by its cover”: two cases of intestinal adenocarcinoma as the first manifestation of Crohn’s disease
  89. Endometrial Endometrioid Carcinoma Metastases Show Decreased ER-Alpha and PR-A Expression Compared to Matched Primary Tumors
  90. Overexpression of pyruvate dehydrogenase kinase supports dichloroacetate as a candidate for cutaneous melanoma therapy
  91. LÚPUS ERITEMATOSO CUTÂNEO - CORRELAÇÃO CLÍNICOPATOLÓGICA DE MANIFESTAÇÕES CUTÂNEAS ESPECÍFICAS
  92. RE: TERT Promoter Mutation Status as an Independent Prognostic Factor in Cutaneous Melanoma
  93. Endometrial Carcinoma in Portugal
  94. A transcriptomic signature mediated by HOXA9 promotes human glioblastoma initiation, aggressiveness and resistance to temozolomide
  95. Pathophysiology of Infantile Pulmonary Arterial Hypertension Induced by Monocrotaline
  96. Pathology, therapy and prognosis of papillary renal carcinoma
  97. AIRP Best Cases in Radiologic-Pathologic Correlation: Gastroblastoma: A Rare Biphasic Gastric Tumor
  98. Low frequency of TERT promoter mutations in gastrointestinal stromal tumors (GISTs)
  99. Evaluation of colon cancer histomorphology: a comparison between formalin and PAXgene tissue fixation by an international ring trial
  100. TERT Promoter Mutations in Skin Cancer: The Effects of Sun Exposure and X-Irradiation
  101. Telomerase promoter mutations in cancer: an emerging molecular biomarker?
  102. Prognostic significance of TERT promoter mutations in follicular cell-derived thyroid carcinomas
  103. Transcription factor NRF2 protects mice against dietary iron-induced liver injury by preventing hepatocytic cell death
  104. Mitochondrial D310 D-Loop instability and histological subtypes in radiation-induced cutaneous basal cell carcinomas
  105. Human papillomaviruses in intraepithelial neoplasia and squamous cell carcinoma of the conjunctiva
  106. PNET with neuroendocrine differentiation of the lung
  107. Tactoid body features in a Schwann cell hamartoma of colonic mucosa
  108. Frequency of TERT promoter mutations in human cancers
  109. GNAQ and BRAF mutations show differential activation of the mTOR pathway in human transformed cells
  110. Feasibility of Fine-Needle Aspiration in the Diagnosis of Two Unusual Childhood Jaw Tumor Types: Prognoma and Cementifying Fibroma
  111. Analysis of a synchronous gliosarcoma and meningioma with long survival: A case report and review of the literature
  112. Multiple Hepatic Inflammatory Pseudotumours Diagnosed after Laparoscopic Excisional Biopsy
  113. Simultaneous presentation of Kaposi sarcoma and HHV8-associated large B-cell lymphoma in the same lymph node: A rare diagnosis in an HIV-negative patient
  114. Front & Back Matter
  115. Loss of WNK2 expression by promoter gene methylation occurs in adult gliomas and triggers Rac1-mediated tumour cell invasiveness
  116. Human periprostatic white adipose tissue is rich in stromal progenitor cells and a potential source of prostate tumor stroma
  117. Molecular alterations and expression of succinate dehydrogenase complex in wild-type KIT/PDGFRA/BRAF gastrointestinal stromal tumors
  118. Oral squamous cell carcinoma in a Crohn's disease patient taking azathioprine: Case report and review of the literature
  119. mTOR Pathway Overactivation in BRAF Mutated Papillary Thyroid Carcinoma
  120. 295 Protein Kinase WNK2 Was Correlated With Poor Outcome and Malignant Behavior in Glioma Cell Lines
  121. Insights into melanoma: targeting the mTOR pathway for therapeutics
  122. Surgical Treatment of Gastrointestinal Stromal Tumors (GISTs)
  123. The mTOR Signalling Pathway in Human Cancer
  124. Melanocytic Tumour in a Black Sheep never exposed to Ultraviolet Radiation
  125. Downregulation of RKIP Is Associated with Poor Outcome and Malignant Progression in Gliomas
  126. A Clear Cell Renal Cell Carcinoma Inhibiting the Response to Intravitreal Antivascular Endothelial Growth Factor Therapy in Wet Age-Related Macular Disease
  127. Paraganglioma of seminal vesicle and chromophobe renal cell carcinoma: a case report and literature review
  128. ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms: Colorectal Neuroendocrine Neoplasms
  129. ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms: Functional Pancreatic Endocrine Tumor Syndromes
  130. ENETS Consensus Guidelines for the Management of Patients with Gastroduodenal Neoplasms
  131. ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary
  132. ENETS Consensus Guidelines for the Management of Patients with Neuroendocrine Neoplasms from the Jejuno-Ileum and the Appendix Including Goblet Cell Carcinomas
  133. ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms of the Digestive System: Well-Differentiated Pancreatic Non-Functioning Tumors
  134. Author Index Vol. 95, No. 2
  135. A novel germline SDHB mutation in a gastrointestinal stromal tumor patient without bona fide features of the Carney–Stratakis dyad
  136. Abdominal inflammatory myofibroblastic tumor
  137. Endometrial Carcinomas
  138. Ascites as a Presenting Sign of Disseminated Tuberculosis in an Immunocompetent Patient
  139. Impact of EGFR Genetic Variants on Glioma Risk and Patient Outcome
  140. Plenary Oral Free Paper Sessions
  141. Black esophagus
  142. Vascular Ehlers-Danlos syndrome: A case with fatal outcome
  143. Human Endometrium Ultrastructure During the Implantation Window
  144. Identification of De Novo Germline Mutations in the HRPT2 Gene in Two Apparently Sporadic Cases with Challenging Parathyroid Tumor Diagnoses
  145. Dysplasia surveillance in an ulcerative colitis patient: Successful detection with Narrow band imaging and magnification
  146. Sarcoma pleomórfico primário do pulmão — 11 anos de sobrevivência
  147. Primary pleomorphic sarcoma of lung – 11 year survival
  148. mTOR pathway activation in cutaneous melanoma is associated with poorer prognosis characteristics
  149. Analysis of GNAQ mutations, proliferation and MAPK pathway activation in uveal melanomas
  150. Idiopathic Infantile Arterial Calcification: A Rare Cause of Sudden Unexpected Death in Childhood
  151. 78 Analysis of raf kinase inhibitor protein (RKIP) expression as a prognostic marker for glioblastomas
  152. 95 Associations between functional EGFR polymorphisms and glioma risk
  153. Endometrial endometrioid adenocarcinoma associated with primitive neuroectodermal tumour of the uterus: a poor prognostic subtype of uterine tumours
  154. Prognostic value of MGMT promoter methylation in glioblastoma patients treated with temozolomide-based chemoradiation: A Portuguese multicentre study
  155. Evaluation of the mTOR pathway in ocular (uvea and conjunctiva) melanoma
  156. Angiogenesis and Breast Cancer
  157. ENETS Consensus Guidelines for the Management of Bone and Lung Metastases from Neuroendocrine Tumors
  158. ENETS Consensus Guidelines for the Management of Peritoneal Carcinomatosis from Neuroendocrine Tumors
  159. ENETS Consensus Guidelines for the Management of Brain, Cardiac and Ovarian Metastases from Neuroendocrine Tumors
  160. Author Index Vol. 91, 2010
  161. Densidade microvascular e prognóstico de tumores neuro-endócrinos gastro-entero-pancreáticos
  162. Requisitos mínimos para um relatório de Anatomia Patológica de tumores neuroendócrinos.
  163. Effects of Diabetes Mellitus, Pressure-Overload and Their Association on Myocardial Structure and Function
  164. Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas
  165. Loss of RKIP expression is associated with poor survival in GISTs
  166. Epidermolytic hyperkeratosis with palmoplantar keratoderma in a patient with KRT10 mutation
  167. Low frequency of MAP kinase pathway alterations inKITandPDGFRAwild-type GISTs
  168. Low-Grade Endometrial Stromal Sarcoma and Undifferentiated Endometrial Sarcoma: A Comparative Analysis Emphasizing the Importance of Distinguishing Between These Two Groups
  169. TP53 germline mutations in Portugal and genetic modifiers of age at cancer onset
  170. Características clínico-laboratoriais e sobrevida em doentes com tumores neuroendócrinos do estômago
  171. Restrictive dermopathy—a lethal congenital laminopathy. Case report and review of the literature
  172. Cryptic chromosome rearrangement resulting in SYT-SSX2 fusion gene in a monophasic synovial sarcoma
  173. 583 POSTER Analysis of MAP kinase signalling pathway in KIT & PDGFRA wild-type GISTs
  174. Clinicopathological features of 45,X/46,Xidic(Y) mosaicism and therapeutic implications: case report
  175. Surgical Margin Status and Prognosis of Gastrointestinal Stromal Tumor
  176. Clear Cell Change in Colonic Polyps
  177. Composite Adenomatoid Tumor and Myelolipoma of Adrenal Gland: Report of 2 Cases
  178. Epithelial-myoepithelial parotid carcinoma after kidney transplantation
  179. TP53 codon 72 polymorphism in susceptibility, overall survival, and adjuvant therapy response of gliomas
  180. Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumors – Well-Differentiated Jejunal-Ileal Tumor/Carcinoma
  181. Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumours: Well-Differentiated Colon and Rectum Tumour/Carcinoma
  182. Consensus Guidelines for the Management of Patients with Liver Metastases from Digestive (Neuro)endocrine Tumors: Foregut, Midgut, Hindgut, and Unknown Primary
  183. Author Index Vol. 87, No. 1, 2008
  184. Title Page / Table of Contents
  185. Poorly-Differentiated Endocrine Carcinomas of Midgut and Hindgut Origin
  186. Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumours: Well-Differentiated Tumour/Carcinoma of the Appendix and Goblet Cell Carcinoma
  187. Splenic hamartomas in a dog
  188. Molecular alterations of KIT and PDGFRA in GISTs: evaluation of a Portuguese series
  189. TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system
  190. A subset of colorectal carcinomas express c-KIT protein independently of BRAF and/or KRAS activation
  191. Association between Functional EGF+61 Polymorphism and Glioma Risk
  192. Multiple Myeloma Presenting with Malabsorption
  193. Gastrinoma (Duodenal and Pancreatic)
  194. Poorly Differentiated Carcinomas of the Foregut (Gastric, Duodenal and Pancreatic)
  195. Rare Functioning Pancreatic Endocrine Tumors
  196. Well-Differentiated Duodenal Tumor/Carcinoma (Excluding Gastrinomas)
  197. Well-Differentiated Gastric Tumors/Carcinomas
  198. Well-Differentiated Pancreatic Tumor/Carcinoma: Insulinoma
  199. Orbital Metastasis as a Rare Form of Clinical Presentation of Non-small Cell Lung Cancer
  200. Deep-Seated Congenital Juvenile Xanthogranuloma
  201. Determining the least time required for measuring energy expenditure in premature neonates
  202. An infant with bullous pemphigoid
  203. Molecular Alterations of KIT Oncogene in Gliomas
  204. 183 POSTER Molecular alterations of KIT and PDGFR-alpha; in GISTs - A Portuguese experience
  205. Fluid supplementation for neonatal hyperbilerubinemia
  206. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system
  207. Identification in Human Brain Tumors of DNA Sequences Specific for SV40 Large T Antigen
  208. Well-Differentiated Pancreatic Nonfunctioning Tumors/Carcinoma
  209. Title Page / Table of Contents
  210. Author Index Vol. 84, No. 3, 2006
  211. Differential Prox-1 and CD 31 expression in mucousae, cutaneous and soft tissue vascular lesions and tumors
  212. Colon stenosis in a patient with ulcerative colitis as a manifestation of mixed müllerian tumor of the peritoneum
  213. Gingival Hyperplasia as a First Manifestation of Crohn's Disease
  214. Colonic Gastrointestinal Autonomic Nervous Tumor in a Patient with Crohn’s Disease
  215. Esophageal Gist: Therapeutic implications of an uncommon presentation of a rare tumor
  216. Epithelioid hemangioendothelioma and multiple thoraco-lumbar lateral meningoceles: two rare pathological entities in a patient with NF-1
  217. Molecular Characterization of PDGFR‐α/PDGF‐A and c‐KIT/SCF in Gliosarcomas
  218. Mutation analysis of B-RAF gene in human gliomas
  219. Malignant peripheral nerve sheath tumour-like primary cutaneous malignant melanoma
  220. August 2003: 47-year-old female with a 7-year history of osteomalacia and hypophosphatemia
  221. 31. Biopsia aspirativa transtorácica por agulha fina para o diagnóstico de lesões pulmonares
  222. Lipomatous haemangiopericytoma (adipocytic variant of solitary fibrous tumour) of the thyroid
  223. Pathologic Quiz Case: A 53-Year-Old Man With a Slowly Enlarging Mass in the Right Leg
  224. Primary Cutaneous Malignant Melanoma With Lipoblast-like Cells
  225. Cutaneous Malignant Melanoma: The Great Simulator
  226. Expression of c-met Tyrosine Kinase Receptor Is Biologically and Prognostically Relevant for Primary Cutaneous Malignant Melanomas
  227. Intraclonal diversity in a Sezary syndrome with a differential response to 2-deoxycoformycin of the two lymphoma cell populations
  228. Pathologic Quiz Case: A 36-Year-Old Woman With Muscle Pain and Weakness
  229. Classic Kaposi's sarcoma of the tongue: Case report with emphasis on the differential diagnosis
  230. Idiopathic Perforation of the Gallbladder: A Novel Differential Diagnosis of Acute Abdomen
  231. Idiopathic Perforation of the Gallbladder: A Novel Differential Diagnosis of Acute Abdomen
  232. Differential Ki67 and bcl-2 immunoexpression in solid-glandular and spindle cell components of biphasic synovial sarcoma: a double immunostaining assessment with cytokeratin and vimentin
  233. Carcinoma secretor da mama no adulto: existem parâmetros bem definidos para decisão terapêutica?
  234. Congenital composite hemangioendothelioma: case report and reappraisal of the hemangioendothelioma spectrum
  235. Response to Cyclosporine in a Patient With Disseminated Granuloma Annulare Associated With CD4+/CD8+(dim)/CD56+ Large Granular Lymphocytic Leukemia
  236. Chronic Eosinophilic Leukaemia Presenting with Erythroderma, Mild Eosinophilia and Hyper-IgE: Clinical, Immunological and Cytogenetic Features and Therapeutic Approach
  237. Hyaline Cell-rich Chondroid Syringoma: Case Report and Review of the Literature
  238. Cutaneous alternariosis by Alternaria chartarum in a renal transplanted patient
  239. Primary acinic cell-like carcinoma of the breast-a variant with good prognosis?
  240. Genetic Profile of Gliosarcomas
  241. Adenocarcinoma of the cervix
  242. Microsatellite instability is not associated with degree of malignancy and p53 expression of gastrointestinal stromal tumours
  243. Esophageal inflammatory pseudotumor associated with a pseudodiverticulosis cyst: two inter-related lesions?
  244. Time of remodelling of the patella tendon graft in anterior cruciate ligament surgery: an histological and immunohistochemical study in a rabbit model
  245. Synovial sarcoma. Evaluation of Prognosis with Emphasis on the Study of DNA Ploidy and Proliferation (PCNA and Ki‐67) Markers
  246. Nuclear localization of SYT, SSX and the synovial sarcoma-associated SYT-SSX fusion proteins
  247. Synovial sarcoma: immunohistochemical expression of p-glycoprotein and glutathione s-transferase-pi and clinical drug resistance
  248. Critical Commentary
  249. Critical Commentary
  250. Proliferative Activity of Synovial Sarcoma: An Immunohistochemical Evaluation of Ki-67 Labeling Indices of 52 Primary and Recurrent Tumors
  251. Immunohistochemical Profile of Synovial Sarcoma with Emphasis on the Epithelial-type Differentiation
  252. Phacolytic glaucoma and lens-induced uveitis
  253. Critical Commentary
  254. Critical Commentary
  255. Primary liver cancer in genetic hemochromatosis: A clinical, pathological, and pathogenetic study of 54 cases
  256. The Ultrastructural Spectrum of Synovial Sarcomas: A Study of the Epithelial Type Differentiation of Primary Tumors, Recurrences, and Metastases
  257. Congenital Hereditary Corneal Dystrophy: Histologic and Ultrastructural Assessment of a Peculiar Polimorphic Recessive Form
  258. Dermatofibrosarcoma Protuberans
  259. Round cell sarcoma after clear cell sarcoma remission
  260. Thymic Tumors
  261. Abnormal Organization of the Human Retina in a Genetic Disorder (Bloch-Sulzberger Syndrome)
  262. Cytogenetic study of a sclerosing stromal tumor of the ovary
  263. Common arterial trunk associated with absence of one atrioventricular connexion